BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 33652403)

  • 1. Health Technology Assessment (HTA) and Access Policies.
    Stühlinger V
    Eur J Health Law; 2020 May; 27(3):274-289. PubMed ID: 33652403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HEALTH TECHNOLOGY ASSESSMENT IN TURKEY.
    Kahveci R; Koç EM; Küçük EÖ
    Int J Technol Assess Health Care; 2017 Jan; 33(3):402-408. PubMed ID: 28595660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. INTRODUCTION OF HEALTH TECHNOLOGY ASSESSMENT FOR MEDICINES IN SLOVAKIA.
    Tesar T; Hloska A; Wawruch M; Lehocka L; Snopkova M; Masarykova L
    Int J Technol Assess Health Care; 2017 Jan; 33(3):345-349. PubMed ID: 28434416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proposal for a regulation on health technology assessment in Europe - opinions of policy makers, payers and academics from the field of HTA.
    Vella Bonanno P; Bucsics A; Simoens S; Martin AP; Oortwijn W; Gulbinovič J; Rothe C; Timoney A; Ferrario A; Gad M; Salem A; Hoxha I; Sauermann R; Kamusheva M; Dimitrova M; Petrova G; Laius O; Selke G; Kourafalos V; Yfantopoulos J; Magnusson E; Joppi R; Jakupi A; Bochenek T; Wladysiuk M; Furtado C; Marković-Peković V; Mardare I; Meshkov D; Fürst J; Tomek D; Cortadellas MO; Zara C; Haycox A; Campbell S; Godman B
    Expert Rev Pharmacoecon Outcomes Res; 2019 Jun; 19(3):251-261. PubMed ID: 30696372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health technology assessment of medical devices: What is different? An overview of three European projects.
    Schnell-Inderst P; Mayer J; Lauterberg J; Hunger T; Arvandi M; Conrads-Frank A; Nachtnebel A; Wild C; Siebert U
    Z Evid Fortbild Qual Gesundhwes; 2015; 109(4-5):309-18. PubMed ID: 26354131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DEVELOPMENT OF HEALTH TECHNOLOGY ASSESSMENT IN ROMANIA.
    Scintee SG; Ciutan M
    Int J Technol Assess Health Care; 2017 Jan; 33(3):371-375. PubMed ID: 28436346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. OVERVIEW ON THE CURRENT IMPLEMENTATION OF HEALTH TECHNOLOGY ASSESSMENT IN THE HEALTHCARE SYSTEM IN HUNGARY.
    Németh B; Csanádi M; Kaló Z
    Int J Technol Assess Health Care; 2017 Jan; 33(3):333-338. PubMed ID: 28434433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What has health technology assessment ever done for us?
    Löblová O
    J Health Serv Res Policy; 2018 Apr; 23(2):134-136. PubMed ID: 29235367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CURRENT IMPLEMENTATION OF HEALTH TECHNOLOGY ASSESSMENT IN HEALTHCARE SYSTEM IN SLOVENIA.
    Prevolnik Rupel V
    Int J Technol Assess Health Care; 2017 Jan; 33(3):360-364. PubMed ID: 28434423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HEALTH TECHNOLOGY ASSESSMENT IN CENTRAL-EASTERN AND SOUTH EUROPE COUNTRIES: BOSNIA AND HERZEGOVINA.
    Guzvic V; Catic T; Kostic M
    Int J Technol Assess Health Care; 2017 Jan; 33(3):390-395. PubMed ID: 28434417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Policy developments of health technology assessment in the European Union].
    Baran-Kooiker A; Czech M; Hołownia-Voloskova M
    Postepy Biochem; 2019 Nov; 65(4):319-321. PubMed ID: 31945287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PRICING, REIMBURSEMENT, AND HEALTH TECHNOLOGY ASSESSMENT OF MEDICINAL PRODUCTS IN BULGARIA.
    Benisheva-Dimitrova T; Sidjimova D; Cherneva D; Kralimarkov N
    Int J Technol Assess Health Care; 2017 Jan; 33(3):365-370. PubMed ID: 28831942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hospital-based health technology assessment (HTA) in Finland: a case study on collaboration between hospitals and the national HTA unit.
    Halmesmäki E; Pasternack I; Roine R
    Health Res Policy Syst; 2016 Apr; 14():25. PubMed ID: 27044400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health technology assessment of medical devices: a survey of non-European union agencies.
    Ciani O; Wilcher B; Blankart CR; Hatz M; Rupel VP; Erker RS; Varabyova Y; Taylor RS
    Int J Technol Assess Health Care; 2015 Jan; 31(3):154-65. PubMed ID: 26044729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The transferability of health technology assessment: the European perspective with focus on central and Eastern European countries.
    Németh B; Goettsch W; Kristensen FB; Piniazhko O; Huić M; Tesař T; Atanasijevic D; Lipska I; Kaló Z
    Expert Rev Pharmacoecon Outcomes Res; 2020 Aug; 20(4):321-330. PubMed ID: 32500749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health technology assessment in Finland.
    Mäkelä M; Roine RP
    Int J Technol Assess Health Care; 2009 Jul; 25 Suppl 1():102-7. PubMed ID: 19500439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How Can Pricing and Reimbursement Policies Improve Affordable Access to Medicines? Lessons Learned from European Countries.
    Vogler S; Paris V; Ferrario A; Wirtz VJ; de Joncheere K; Schneider P; Pedersen HB; Dedet G; Babar ZU
    Appl Health Econ Health Policy; 2017 Jun; 15(3):307-321. PubMed ID: 28063134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Policies for Use of Real-World Data in Health Technology Assessment (HTA): A Comparative Study of Six HTA Agencies.
    Makady A; Ham RT; de Boer A; Hillege H; Klungel O; Goettsch W;
    Value Health; 2017 Apr; 20(4):520-532. PubMed ID: 28407993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health technology assessment and health care in the European Union.
    Banta D; Oortwijn W
    Int J Technol Assess Health Care; 2000; 16(2):626-35. PubMed ID: 10932427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Introduction: health technology assessment and the European Union.
    Banta D; Oortwijn W
    Int J Technol Assess Health Care; 2000; 16(2):299-302. PubMed ID: 10932410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.